“…Nevertheless, several studies have indicated that carriers with more than 300 repeats of expanded CGG show a mild or asymptomatic phenotype [ 20 , 127 ]. Beyond NIID, expanded CGG repeats in NOTCH2NLC are occasionally related to a small proportion of Parkinson's disease (PD) [ 65 , 97 , 110 ], multiple system atrophy (MSA) [ 29 ], essential tremor (ET) [ 105 ], degenerative dementia [ 4 , 101 ], ALS [ 46 , 130 ], inherited peripheral neuropathy [ 118 ], distal motor neuropathy [ 122 , 128 ], mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) [ 57 , 123 ], and oculopharyngodistal myopathy (OPDM) [ 127 ]. Intriguingly, CGG expansion in NOTCH2NLC was rarely detected in NIID cases reported in people of Caucasian descent, suggesting that NIID is likely to be genetically heterogeneous among different ethnic groups [ 15 ].…”